Satellite Symposium: Interactive case studies for an IDH1 mutated patient ineligible for intensive chemotherapy - From diagnosis to treatment

ESH eLearning, Faculty / Presenters, 411203

Panel discussion

ESH eLearning, Faculty / Presenters, 411202

Case-based lecture: MRD directed therapy- a new therapeutic option

ESH eLearning, Andrew Wei, 411200

Case-based lecture: Menin inhibitors

ESH eLearning, Eunice Wang, 411199

Interactive case: Frontline Blinatumumab for all in ALL?

ESH eLearning, Mark Litzow, 411198

Panel discussion

ESH eLearning, Faculty / Presenters, 411197

Case-based lecture: Mixed phenotypic acute leukemias: for example: MPAL with t(v;11q23.3); KMT2A-rearranged

ESH eLearning, Etan Orgel, 411196

Case-based lecture: Extramedullary / CNS relapse in ALL

ESH eLearning, Nicolas Boissel, 411195

Case-based lecture: Blastic plasmacytoid dendritic cell neoplasm

ESH eLearning, Andrew Lane, 411194

Interactive case: Germ-line-mutation-based AML

ESH eLearning, Marie Sébert, 411193

How do the new WHO / ICC /ELN classifications impact clinical decision making?

ESH eLearning, Richard Stone, 411192

Welcome words

ESH eLearning, Faculty / Presenters, 411191

Closing remarks

ESH eLearning, Faculty / Presenters, 405454

Panel discussion

ESH eLearning, Faculty / Presenters, 405453

Therapeutic targeting of IDH1/IDH2

ESH eLearning, Eunice Wang, 405452

Therapeutic targeting of FLT3

ESH eLearning, Alexander Perl, 405451

Surface Antigen Targeting in AML: CD47 and Beyond

ESH eLearning, Ravi Majeti, 405450

NGS-based molecular MRD monitoring in AML

ESH eLearning, Peter VALK, 405449

Panel discussion

ESH eLearning, Faculty / Presenters, 405448

Molecular mechanisms driving secondary AML transformation

ESH eLearning, Coleman Lindsley, 405446

The biologic heterogeneity of secondary AML

ESH eLearning, Robert HASSERJIAN, 405445

Panel discussion

ESH eLearning, Faculty / Presenters, 405444

Therapeutic targeting of Menin

ESH eLearning, Eytan Stein, 405443

Therapeutic targeting of NPM1

ESH eLearning, Hannah Uckelmann, 405442

Therapeutic targeting of splicing factors

ESH eLearning, Matthew WALTER, 405441

Panel discussion

ESH eLearning, Faculty / Presenters, 405439

Functional single cell assessments in leukemia

ESH eLearning, Philipp Staber, 405438

Harnessing functional assays for precision medicine in AML

ESH eLearning, Raphael Itzykson, 405436

Panel discussion

ESH eLearning, Faculty / Presenters, 405435

Therapeutic targeting of BCL-2

ESH eLearning, Courtney DiNardo, 405432

Panel discussion

ESH eLearning, Faculty / Presenters, 405431

Germline predisposition to myeloid malignancy

ESH eLearning, Katherine R. CALVO, 405430

Targeted protein degradation for the treatment of hematologic malignancies

ESH eLearning, Benjamin Ebert, 405428

Panel discussion

ESH eLearning, Faculty / Presenters, 405427

AML relapse after allo-HCT: hiding in plain sight

ESH eLearning, John DiPersio, 405426

Targeting of tumor necrosis factor receptors/CD70 in leukemia

ESH eLearning, Adrian Ochsenbein, 405425

Immunotherapeutic targeting of AML and MDS

ESH eLearning, Saar Gill, 405424

The immune landscape of AML and its correlation with immunotherapy outcomes

ESH eLearning, Sergio RUTELLA, 405423

Panel discussion

ESH eLearning, Faculty / Presenters, 405422

Targeting aberrant gene control in AML

ESH eLearning, Alex Kentsis, 405421

Panel discussion

ESH eLearning, Faculty / Presenters, 405418

Where, when and how? Characterising the properties of age-related haematopoietic clones

ESH eLearning, Paresh Vyas, 405416

Interrogating clonal evolution in acute myeloid leukemia

ESH eLearning, Linde Miles, 405415

Panel discussion

ESH eLearning, Faculty / Presenters, 405414

Causes and consequences of clonal haematopoiesis

ESH eLearning, George Vassiliou, 405413

Evolution of clonal haematopoiesis to AML

ESH eLearning, Caroline WATSON, 405412

Linking mutational processes to leukemic development

ESH eLearning, Mathijs Sanders, 405411

Welcome words

ESH eLearning, Faculty / Presenters, 405410

Conference Book (PDF)

ESH eLearning, Faculty / Presenters, 405496

Closing Remarks

ESH eLearning, Michael Hallek, 405355

Panel discussion

ESH eLearning, Faculty / Presenters, 405354

Circulating tumor DNA in chronic lymphocytic leukaemia

ESH eLearning, Moritz FÜRSTENAU, 405353

Circulating tumor DNA in primary CNS lymphoma

ESH eLearning, Stefan Alig, 405352

Circulating tumor DNA as predictor for survival in diffuse large B-cell lymphoma

ESH eLearning, Ash Alizadeh, 405351

Panel discussion

ESH eLearning, Faculty / Presenters, 405350

Multi-Targeted Therapy for Diffuse Large B-cell Lymphoma

ESH eLearning, Mark Roschewski, 405349

Timing and duration of targeted therapies, continuous versus MRD-guided versus time-limited?

ESH eLearning, Paolo Ghia, 405348

Venetoclax in combination with other agents in chronic lymphocytic leukaemia and non-Hodgkin lymphoma

ESH eLearning, Michael Hallek, 405347

Panel discussion

ESH eLearning, Faculty / Presenters, 405346

CDK9 inhibitors for double refr. Ibru venetoclax refractory lymphoma/chronic lymphocytic leukaemia

ESH eLearning, Alexey Danilov, 405345

Function and targeting of MALT1 in aggressive lymphomas

ESH eLearning, Daniel Krappmann, 405344

BTK inhibitors in aggressive lymphoma

ESH eLearning, Mark Roschewski, 405343

Panel discussion

ESH eLearning, Faculty / Presenters, 405342

Microenvironmental niche of indolent lymphoma

ESH eLearning, Karin Tarte, 405341

Microenvironment of chronic lymphocytic leukaemia

ESH eLearning, Silvia Deaglio, 405339

Panel discussion

ESH eLearning, Faculty / Presenters, 405338

PI3K inhibitors

ESH eLearning, Georg Lenz, 405337

Tafasitamab CD19 + Len and novel bispecific Ab strategies

ESH eLearning, Gilles SALLES, 405336

Bispecific antibodies in non-Hodgkin lymphoma

ESH eLearning, Martin Hutchings, 405335

Antibody-drug conjugates in relapsed/refractory non-Hodgkin lymphoma

ESH eLearning, Laurie Sehn, 405334

Panel discussion

ESH eLearning, Faculty / Presenters, 405333

“Off-the-shelf” CAR constructs

ESH eLearning, David Miklos, 405332

Novel conceptual design of innovative (CART and NK cell) constructs for lymphoma

ESH eLearning, Catherine Bollard, 405331

CAR T-cells for B-cell lymphoma

ESH eLearning, Jason WESTIN, 405330

Panel discussion

ESH eLearning, Faculty / Presenters, 405329

Landscape and evolution in mantle cell lymphoma

ESH eLearning, Silvia Bea, 405328

Epigenetic dysregulation in diffuse large B-cell lymphoma

ESH eLearning, Ari Melnick, 405327

Mechanisms of B cell lymphomagenesis: Pervasive hypermutation of super-enhancers dysregulates oncogene expression Pervasive hypermutation of super-enhancers dysregulates oncogene expression

ESH eLearning, Riccardo Dalla-Favera, 405326

Panel discussion

ESH eLearning, Faculty / Presenters, 405325

T-cell lymphoma subtypes

ESH eLearning, Javeed Iqbal, 405324

Single cell analytics in lymphoid malignancies - A conceptual overview

ESH eLearning, Catherine Wu, 405322

Panel discussion

ESH eLearning, Faculty / Presenters, 405321

High grade B-cell lymphoma

ESH eLearning, David Scott, 405320

Building lymphoma diffuse large B-cell lymphoma models

ESH eLearning, Daniel HODSON, 405318

Conference Book (PDF)

ESH eLearning, Faculty / Presenters, 405495

Conference Book (PDF)

ESH eLearning, Faculty / Presenters, 404819

Interactive case: Allo after CAR-T

ESH eLearning, Anna Sureda, 403600

Case-based lecture: Treatment after CAR-T failure in diffuse large B-cell lymphoma: bispecific antibody

ESH eLearning, Elizabeth Budde, 403598

Case-based lecture: CAR-T resistance mechanisms

ESH eLearning, Michael Green, 403597

Interactive case: Relapse in multiple myeloma after CAR-T

ESH eLearning, Lukas Scheller, 403596

Interactive case: CARs and comorbidities

ESH eLearning, Jordan Gauthier, 403595

Case-based lecture: Diffuse large B-cell lymphoma - UK experience

ESH eLearning, Andrea Kuhnl, 403594

Case-based lecture: Diffuse large B-cell lymphoma - US experience

ESH eLearning, Frederick Locke, 403593

Interactive case: Mantle cell lymphoma

ESH eLearning, Gloria Iacoboni, 403592

Pro bispecific antibody

ESH eLearning, Elizabeth Budde, 403591

Pro CAR-T

ESH eLearning, Jeremy Abramson, 403590

Patient’s view of CAR T-cell therapy

ESH eLearning, Jonathan Clark, 403589

Patient perspective

ESH eLearning, Hans Scheurer, 403588

Eligibility and rapid progression

ESH eLearning, Marie José Kersten, 403587

Interactive case: EBMT recommendations

ESH eLearning, Claire Roddie, 403586